FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine-Reference-Cited by-同舟云学术

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine

Author:

Rothrock John F.¹,Adams Aubrey Manack²,Lipton Richard B.³,Silberstein Stephen D.⁴,Jo Esther²,Zhao Xiang⁵,Blumenfeld Andrew M.⁶,

Affiliation:

1. Department of Neurology George Washington University School of Medicine Washington DC USA

2. Global Medical Affairs Allergan plc Irvine CA USA

3. Department of Neurology Montefiore Headache Center Albert Einstein College of Medicine Bronx NY USA

4. Department of Neurology Jefferson Headache Center Philadelphia PA USA

5. Department of Statistics Pharmaceutical Product Development Austin TX USA

6. Department of Neurology Headache Center of Southern California The Neurology Center Carlsbad CA USA

Funder

Allergan

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

Reference35 articles.

1. 2017 Allergan Ltd. plc Dublin Ireland Botox [package insert]

2. 2015 Allergan Ltd. Marlow Buckinghamshire UK: Botox [summary of product characteristics]

3. 2014 Allergan plc Markham Ontario Canada: Botox [product monograph]

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献